Pitcairn CO Ani Pharmaceuticals Inc Transaction History

Pitcairn CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$30.35 - $67.14 $144,587 - $319,854	-4,764 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$55.65 - $79.83 $41,904 - $60,111	753 Added 18.77%	4,764 $293,000
Q3 2019 Nov 12, 2019	SELL	$64.7 - $85.39 $15,722 - $20,749	-243 Reduced 5.71%	4,011 $292,000
Q2 2019 Aug 12, 2019	BUY	$67.77 - $82.2 $1,829 - $2,219	27 Added 0.64%	4,254 $350,000
Q1 2019 May 07, 2019	BUY	$45.83 - $70.54 $193,723 - $298,172	4,227 New	4,227 $299,000

Q4 2018 Feb 12, 2019	SELL	$41.17 - $56.44 $156,446 - $214,472	-3,800 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$52.95 - $71.34 $15,726 - $21,187	-297 Reduced 7.25%	3,800 $214,000
Q2 2018 Aug 02, 2018	BUY	$56.38 - $68.08 $4,284 - $5,174	76 Added 1.89%	4,097 $274,000
Q1 2018 May 11, 2018	BUY	$56.98 - $72.41 $229,116 - $291,160	4,021 New	4,021 $234,000

283

20.5M

30.6K

30.7K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.46B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.